GlassScriptPhysician profile
Matthias M Albin
NPI 1528328754
$3,148.15
in general payments reported to CMS, 2019-2025
11 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,990 · 2020: $24.01 · 2021: $105 · 2022: $107 · 2023: $138 · 2024: $436 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680 · Travel and Lodging: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.15 |
| Travel and Lodging | $242.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,643.13 | 2019 | |
| Stryker Corporation | $500.12 | 2023-2025 | Optablate, Omnicurve, Spinejack |
| Inari Medical, INC. | $251.57 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bard Peripheral Vascular, INC. | $222.66 | 2024-2025 | Dorado, Set Aspirex S 10f 110cm |
| Penumbra, INC. | $205.36 | 2019-2025 | Indigo System |
| Boston Scientific Corporation | $119.33 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $73.55 | 2021 | |
| Argon Medical Devices, INC. | $56.86 | 2019 | |
| Ekos Corporation | $41.28 | 2019 | |
| Terumo Medical Corporation | $22.21 | 2024 | Azur Cx Detachable |
| Pacira Pharmaceuticals Incorporated | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthias Albin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.